المؤلفون: Yalbi I. Balderas-Martínez, Soto Lm, Julio Collado-Vides, Velázquez-Ramírez Da, Adrián Munguía-Reyes, Olayo-Alarcón R, Carlos-Francisco Méndez-Cruz

مصطلحات موضوعية: Computer science, Event (computing), business.industry, Supervised learning, Simple Features, Literature based, Disease, Artificial intelligence, Machine learning, computer.software_genre, business, computer, Manual curation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7709362479c387421f4b53e850609cef
https://doi.org/10.1101/839704

المؤلفون: Matute Ar, Núñez Ochoa L, Vázquez-Briones Db, Vargas-Soto Lm

المصدر: Journal of Veterinary Medicine and Surgery. 1

مصطلحات موضوعية: Pathology, medicine.medical_specialty, biology, business.industry, Agkistrodon bilineatus, Disease, Anorexia, biology.organism_classification, medicine.disease, Lesion, Granuloma, Hyperlipidemia, Medicine, medicine.symptom, business, Depression (differential diagnoses), Cause of death

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cad7fd5f5191fc74fa9d349818f51df0
https://doi.org/10.4172/2574-2868.100015

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: How JA; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jahow@mdanderson.org., Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee S; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hajek R; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morgan MB; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Laberiano Fernandez CD; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arrechedera CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nick A; Texas Oncology, Houston, TX, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coleman R; Texas Oncology, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aajazaeri@mdanderson.org.

المصدر: Med (New York, N.Y.) [Med] 2024 Aug 10. Date of Electronic Publication: 2024 Aug 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

المؤلفون: Madrigal A; Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, H3A 0G1, Canada., Lu T; Lady Davis Institute for Medical Research, Montreal, QC, H3T 1E2, Canada.; Department of Statistical Sciences, University of Toronto, Toronto, ON, M5S 1A1, Canada.; Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI, 53726, USA., Soto LM; Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, H3A 0G1, Canada., Najafabadi HS; Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada. hamed.najafabadi@mcgill.ca.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, H3A 0G1, Canada. hamed.najafabadi@mcgill.ca.; McGill Centre for RNA Sciences, McGill University, Montreal, Canada. hamed.najafabadi@mcgill.ca.

المصدر: Nature communications [Nat Commun] 2024 Aug 03; Vol. 15 (1), pp. 6573. Date of Electronic Publication: 2024 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Single-Cell Analysis*/methods, Humans ; Gene Expression Profiling/methods ; Machine Learning ; Gene Regulatory Networks ; Computational Biology/methods ; Algorithms ; Alternative Splicing

المؤلفون: Apostolides M; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, Canada., Choi B; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA., Navickas A; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.; Present address: Institut Curie, PSL Research University, CNRS UMR3348, INSERM U1278, Orsay, France., Saberi A; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, Canada.; Department of Electrical and Computer Engineering, McGill University, Montreal, Canada., Soto LM; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, Canada., Goodarzi H; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.; Arc Institute, 3181 Porter Drive, Palo Alto, CA, USA., Najafabadi HS; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Victor P. Dahdaleh Institute of Genomic Medicine, Montreal, QC, Canada.; McGill Centre for RNA Sciences, McGill University, Montreal, Canada.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 13. Date of Electronic Publication: 2024 Jul 13.

نوع المنشور: Journal Article; Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Araujo HA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Pechuan-Jorge X; Revolution Medicines (United States), Redwood City, CA, United States., Zhou T; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Do MT; MD Anderson Cancer Center, Houston, Texas, United States., Hu X; The University of Texas MD Anderson Cancer Center, Houston, United States., Rojas Alvarez FR; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salvatierra ME; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ibarguen HP; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lee R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Raghulan R; Revolution Medicines (United States), Redwood City, CA, United States., Shah H; Revolution Medicines (United States), Foster City, California, United States., Moreno Ayala MA; Revolution Medicines (United States), Redwood City, CA, United States., Chen K; Revolution Medicines (United States), Redwood City, CA, United States., Tovbis Shifrin N; Revolution Medicines, Redwood City, CA, United States., Wu S; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Solis Soto LM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Negrao MV; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gibbons DL; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Roth JA; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Heymach JV; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zhang J; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jiang J; Revolution Medicines (United States), Redwood City, CA, United States., Singh M; Revolution Medicines (United States), Redwood City, CA, United States., Smith JAM; Revolution Medicines (United States), Redwood City, CA, United States., Quintana E; Revolution Medicines, Redwood City, CA, United States., Skoulidis F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Cancer discovery [Cancer Discov] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

المؤلفون: Acharya S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Basar R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Daher M; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rafei H; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Li P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Uprety N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ensley E; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shanley M; The University of Texas MD Anderson Cancer Center, Houston, United States., Kumar B; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Banerjee PP; Baylor College of Medicine, Houston, Texas, United States., Melo Garcia L; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lin P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mohanty V; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim KH; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Jiang X; The University of Texas MD Anderson Cancer Center, United States., Pan Y; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Li Y; The University of Texas MD Anderson Cancer Center, Houston, United States., Liu B; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nunez Cortes AK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zhang C; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fathi M; CellChorus, Houston, United States., Rezvan A; University of Houston, Houston, Texas, United States., Montalvo MJ; University of Houston, Houston, TX, United States., Cha SL; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Reyes-Silva F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shrestha R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Guo X; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kundu K; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Biederstadt A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Muniz-Feliciano L; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Deyter GM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kaplan M; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jiang XR; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Liu E; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jain A; Baylor College of Medicine, HOUSTON, United States., Roszik J; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fowlkes NW; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Solis Soto LM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Raso MG; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Khoury JD; University of Nebraska Medical Center, Omaha, United States., Lin P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vega F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Varadarajan N; University of Houston, Houston, Texas, United States., Chen K; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Marin D; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shpall EJ; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rezvani K; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Cancer discovery [Cancer Discov] 2024 Jun 20. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

المؤلفون: Gordon MJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Strati P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee HJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hagemeister FB; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Westin JR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Samaniego F; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vega Vazquez F; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Parra Cuentas ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Solis-Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ma W; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Claret L; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Averill B; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ibanez K; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fayad LE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Flowers CR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Green MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davis RE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Neelapu SS; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fowler NH; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nastoupil LJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 876-885. Date of Electronic Publication: 2023 Nov 20.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/drug therapy , Lymphoma, Follicular*/pathology , Lymphoma, B-Cell, Marginal Zone*/drug therapy , Exanthema*/chemically induced , Exanthema*/drug therapy , Piperidines*, Adenine/*analogs & derivatives, Humans ; Rituximab ; Lenalidomide/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects